[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Zhang et al., 2014 - Google Patents

Chromogranin B: intra‐and extra‐cellular mechanisms to regulate catecholamine storage and release, in catecholaminergic cells and organisms

Zhang et al., 2014

View HTML
Document ID
10108807830147800773
Author
Zhang K
Biswas N
Gayen J
Miramontes‐Gonzalez J
Hightower C
Mustapic M
Mahata M
Huang C
Hook V
Mahata S
Vaingankar S
O'Connor D
Publication year
Publication venue
Journal of neurochemistry

External Links

Snippet

Chromogranin B (CHGB) is the major matrix protein in human catecholamine storage vesicles. CHGB genetic variation alters catecholamine secretion and blood pressure. Here, effective Chgb protein under‐expression was achieved by si RNA in PC 12 cells, resulting …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Similar Documents

Publication Publication Date Title
Nagaoka et al. Increased expression of p62 in expanded polyglutamine‐expressing cells and its association with polyglutamine inclusions
Joch et al. Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels
Wu et al. Autocrine interleukin-10 mediates glucagon-like peptide-1 receptor-induced spinal microglial β-endorphin expression
Magnaghi et al. GABAB receptors in Schwann cells influence proliferation and myelin protein expression
Lee et al. Molecular evolution of multiple forms of kisspeptins and GPR54 receptors in vertebrates
Zhang et al. The interaction of MC3R and MC4R with MRAP2, ACTH, α-MSH and AgRP in chickens
Zhang et al. Chromogranin B: intra‐and extra‐cellular mechanisms to regulate catecholamine storage and release, in catecholaminergic cells and organisms
Mahul-Mellier et al. Alix, making a link between apoptosis-linked gene-2, the endosomal sorting complexes required for transport, and neuronal death in vivo
Mellone et al. Zinc transporter‐1: a novel NMDA receptor‐binding protein at the postsynaptic density
Um et al. Neddylation positively regulates the ubiquitin E3 ligase activity of parkin
Cottrell CGRP receptor signalling pathways
Gozdz et al. GSK3α and GSK3β phosphorylate arc and regulate its degradation
Vergarajauregui et al. AKAP6 orchestrates the nuclear envelope microtubule-organizing center by linking golgi and nucleus via AKAP9
Tachiyama et al. Proteome of ubiquitin/MVB pathway: possible involvement of iron‐induced ubiquitylation of transferrin receptor in lysosomal degradation
Vazquez‐Martinez et al. Rab18 inhibits secretory activity in neuroendocrine cells by interacting with secretory granules
Machado et al. Heat shock cognate protein 70 regulates gephyrin clustering
Dächsel et al. Parkin interacts with the proteasome subunit α4
Houy et al. Oligophrenin-1 connects exocytotic fusion to compensatory endocytosis in neuroendocrine cells
Medina‐Medina et al. p53 promotes its own polyubiquitination by enhancing the HDM2 and HDMX interaction
Palczewska et al. Sumoylation regulates nuclear localization of repressor DREAM
Shakya et al. Increased expression and retention of the secretory chaperone proSAAS following cell stress
KR101384642B1 (en) A pharmaceutical composition containing N-terminal Truncated Ubiquitin C-terminal hydrolase-L1 as a active ingredient for the prevention and treatment of parkinson's disease
Xu et al. Mutually exclusive interactions of EHD1 with GS32 and syndapin II
Blazejczyk et al. Biochemical characterization and expression analysis of a novel EF-hand Ca2+ binding protein calmyrin2 (Cib2) in brain indicates its function in NMDA receptor mediated Ca2+ signaling
Lv et al. Intrathecally administered Apelin-13 alleviated complete Freund’s adjuvant-induced inflammatory pain in Mice